Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, M. T. M.
Right arrow Articles by Brooks, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, M. T. M.
Right arrow Articles by Brooks, D. J.
Neurology 2001;56:1195-1200
© 2001 American Academy of Neurology
Articles

A comparison of 18F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson’s disease

M. T. M. Hu, MRCP, PhD;, S. J. White, DCR(R);, A. H. Herlihy, PhD;, K. R. Chaudhuri, MD, FRCP;, J. V. Hajnal, PhD; and D. J. Brooks, MD, DSc, FRCP

From the MRC Cyclotron Building, Medical Research Council Clinical Sciences Centre, and Division of Neuroscience (Drs. Hu and Brooks), and Robert Steiner MR Unit (Drs. Hu, White, Herlihy, and Hajnal), Imperial College School of Medicine, Hammersmith Hospital; Movement Disorders Unit, Department of Neurology, Guy’s, King’s, and St. Thomas’ School of Medicine, and Institute of Psychiatry (Drs. Hu and Chaudhuri), King’s College; University Hospital of Lewisham (Dr. Chaudhuri); and Institute of Neurology (Dr. Brooks), London, United Kingdom.

Address correspondence and reprint requests to Dr. M.T.M. Hu, MRC Cyclotron Building, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK; e-mail: michele.hu{at}csc.mrc.ac.uk

OBJECTIVE: To quantify structural changes in the substantia nigra of patients with PD with inversion recovery MRI and to compare these with striatal dopaminergic function measured with 18F-dopa PET.

METHODS: The authors studied 10 patients with PD and eight age-matched control subjects with a combination of MR sequences previously reported to be sensitive to nigral cell loss. Striatal regions of interest were defined on T1-weighted MRI coregistered to 18F-dopa PET in all subjects.

RESULTS: Discriminant function analysis of the quantified MR nigral signal correctly classified 83% of the combined PD patient/control group; three of 10 PD cases were incorrectly classified as "normal" (Wilks’ {lambda} = 0.724, p > 0.05). Discriminant function analysis correctly classified 100% of PD patients and control subjects with 18F-dopa PET based on mean caudate and putamen Ki values (Wilks’ {lambda} = 0.065, p < 0.001). Correlations between mean putamen Ki and rostral and caudal nigral MR signal changes and mean caudate Ki and caudal nigral MR signal changes were found (r = -0.76, -0.69, -0.80, p < 0.05).

CONCLUSION: 18F-dopa PET is more reliable than inversion recovery MRI in discriminating patients with moderately severe PD from normal subjects. However, the structural changes detected within the substantia nigra of patients with PD found using inversion recovery MRI correlate with measures of striatal dopaminergic function using 18F-dopa PET.




This article has been cited by other articles:


Home page
 RadiologyHome page
D. A. Hammoud, J. M. Hoffman, and M. G. Pomper
Molecular Neuroimaging: From Conventional to Emerging Techniques
Radiology, October 1, 2007; 245(1): 21 - 42.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.